Overview

Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites

Status:
NOT_YET_RECRUITING

Trial end date:
2027-07-30

Target enrollment:

Participant gender:

Summary

To investigate efficacy and safety of lenvatinib in combination with nivolumab plus chemotherapy in gastric cancer patients with peritoneal metastasis and grade 2 ascites.

Phase:

PHASE1

Details

Lead Sponsor:

Asan Medical Center

Treatments:

lenvatinib